Mabpro, a.s.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours (NCT05698238) | Mabpro, a.s. | 2024-01-01 |
Track Mabpro, a.s. automatically
Every clearance here is in the API, with alerts when new ones post.